LIGAND PHARMACEUTICALS INCORPORATED Exchange Rate Effect on Cash
LIGAND PHARMACEUTICALS INCORPORATED (LGNXZ) reported Exchange Rate Effect on Cash of -$1.82 million for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations · last filed 2025-08-08
- LIGAND PHARMACEUTICALS INCORPORATED effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for the quarter ending 2025-03-31 was -$24.24M, a 189.32% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for the quarter ending 2024-03-31 was $27.14M.
| Period end | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations 3 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations 6 month |
|---|---|---|
| 2025-06-30 | -$1.82M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | -$24.24M 10-Q · filed 2025-05-09 | |
| 2024-06-30 | -$4.82M 10-Q · filed 2025-08-08 | |
| 2024-03-31 | $27.14M 10-Q · filed 2025-05-09 |